4//SEC Filing
NORTHCOTT JOHN 4
Accession 0001209191-22-011437
CIK 0000906709other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:15 PM ET
Size
5.8 KB
Accession
0001209191-22-011437
Insider Transaction Report
Form 4
NORTHCOTT JOHN
SVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-02-16$10.95/sh−4,852$53,129→ 227,802 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $10.77 to $11.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001615000
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 6:15 PM ET
- Size
- 5.8 KB